The cytotoxic effect of the melittin-containing conjugate on cancer cells with higher activity of MMP2 was proven in this study, for example, in the investigated prostate cancer cell line and the additionally investigated ovarian cancer cell line (SK-OV-3 cells). This evidence concerns the gene MMP2 and prostate cancer.